Latent View Analytics Ltd

Latent View Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Latent View Analytics Ltd

₹ 404 2.97%
02 May 4:01 p.m.
latentview.com BSE: 543398 NSE: LATENTVIEW
About

Latent View Analytics Ltd provides analytics services such as data and analytics consulting, business analytics & insights, advanced predictive analytics, data engineering, and digital solutions. The company provides services to blue-chip companies in Technology, BFSI, CPG & Retail, Industrials, and other industry domains.[1]

Key Points

Leadership[1]

<h1>1st Analytics company listed on BSE/NSE</h1>
Website BSE NSE
  • Market Cap ₹ 8,361 Cr.
  • Current Price ₹ 404
  • High / Low ₹ 575 / 340
  • Stock P/E 101
  • Book Value ₹ 57.8
  • Dividend Yield 0.00 %
  • ROCE 11.1 %
  • ROE 7.20 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 6.99 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.0% over last 3 years.
  • Earnings include an other income of Rs.60.8 Cr.
  • Working capital days have increased from 352 days to 551 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Part of Nifty 500 BSE Allcap Nifty Smallcap 250 BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
66.71 60.91 64.99 68.46 69.60 68.90 71.77 73.82 77.03 78.95 82.49 87.82 97.87
34.05 36.79 39.76 41.33 43.69 47.36 47.56 51.28 49.46 53.29 53.70 66.04 103.06
Operating Profit 32.66 24.12 25.23 27.13 25.91 21.54 24.21 22.54 27.57 25.66 28.79 21.78 -5.19
OPM % 48.96% 39.60% 38.82% 39.63% 37.23% 31.26% 33.73% 30.53% 35.79% 32.50% 34.90% 24.80% -5.30%
7.92 10.37 9.36 22.52 14.97 17.39 15.39 21.74 14.69 16.29 20.94 12.56 18.20
Interest 1.17 0.64 0.63 0.69 0.66 0.79 0.77 0.75 0.72 0.65 0.59 0.49 0.47
Depreciation 1.95 1.80 1.87 1.91 1.84 1.91 1.95 2.14 2.09 2.40 2.49 2.28 2.62
Profit before tax 37.46 32.05 32.09 47.05 38.38 36.23 36.88 41.39 39.45 38.90 46.65 31.57 9.92
Tax % 22.48% 23.99% 19.60% 20.60% 22.59% 27.19% 28.69% 24.23% 25.91% 28.38% 28.72% 30.19% 105.75%
29.05 24.36 25.80 37.36 29.71 26.38 26.30 31.35 29.23 27.87 33.25 22.04 -0.57
EPS in Rs 1.45 1.22 1.29 1.84 1.45 1.29 1.28 1.52 1.42 1.35 1.61 1.07 -0.03
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
21 49 78 105 105 115 125 143 207 264 292 347
15 35 57 57 51 69 71 71 121 162 196 269
Operating Profit 6 14 21 49 54 47 54 72 85 102 96 78
OPM % 29% 28% 27% 46% 51% 40% 43% 50% 41% 39% 33% 23%
0 0 1 1 6 11 16 21 21 57 69 61
Interest 0 0 1 0 1 0 3 3 3 3 3 2
Depreciation 0 0 3 3 3 3 6 6 7 7 8 10
Profit before tax 6 14 20 46 57 55 61 84 97 150 154 127
Tax % 0% 0% 12% -0% 4% 13% 17% 20% 21% 22% 26% 35%
6 14 17 46 54 48 51 68 76 117 113 83
EPS in Rs 7.71 17.11 21.50 57.99 67.25 59.20 62.95 83.49 3.79 5.72 5.50 4.00
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 23%
3 Years: 19%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 13%
3 Years: 3%
TTM: -27%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -2%
1 Year: -18%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: 10%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.80 0.80 0.80 0.80 0.81 0.81 0.81 0.81 20 20 21 21
Reserves 10 24 52 100 156 204 256 325 836 963 1,081 1,172
5 6 4 3 1 0 0 28 25 21 22 19
1 2 15 16 10 8 36 9 16 10 19 50
Total Liabilities 17 33 72 119 168 213 293 362 897 1,014 1,143 1,262
2 7 9 7 5 4 33 28 27 21 25 37
CWIP 0 1 0 0 0 0 0 0 0 0 0 0
Investments 3 12 15 66 83 98 73 140 194 391 553 846
12 13 48 47 80 111 188 194 676 602 565 379
Total Assets 17 33 72 119 168 213 293 362 897 1,014 1,143 1,262

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
18 49 16 42 50 48 67 71 27 100
-12 -51 -15 -47 -34 -45 -489 -97 12 -132
-1 -2 -1 -1 -5 -5 450 -3 -0 -2
Net Cash Flow 5 -4 1 -5 12 -2 27 -30 39 -35

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 16 17 69 34 107 72 61 99 73 70 128 103
Inventory Days
Days Payable
Cash Conversion Cycle 16 17 69 34 107 72 61 99 73 70 128 103
Working Capital Days 20 15 62 -7 87 65 110 147 229 183 322 551
ROCE % 59% 58% 41% 26% 25% 28% 16% 16% 15% 11%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
67.21% 67.21% 66.31% 65.74% 65.74% 65.74% 65.42% 65.42% 65.39% 65.39% 65.24% 65.24%
0.93% 1.01% 1.32% 1.66% 1.83% 2.57% 2.54% 2.39% 2.40% 2.66% 2.87% 3.02%
1.90% 1.83% 1.83% 1.81% 1.65% 1.58% 2.45% 4.47% 4.42% 3.65% 3.66% 3.27%
29.96% 29.94% 30.54% 30.79% 30.78% 30.12% 29.59% 27.73% 27.78% 28.30% 28.23% 28.47%
No. of Shareholders 3,25,1263,19,2093,08,0022,94,4722,90,5712,87,6073,01,4522,75,0472,61,8472,55,0742,44,4342,38,450

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls